Correlation Between Viridian Therapeutics and Compass Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Compass Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Compass Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Compass Group PLC, you can compare the effects of market volatilities on Viridian Therapeutics and Compass Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Compass Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Compass Group.

Diversification Opportunities for Viridian Therapeutics and Compass Group

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viridian and Compass is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Compass Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Group PLC and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Compass Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Group PLC has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Compass Group go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Compass Group

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Compass Group. In addition to that, Viridian Therapeutics is 4.54 times more volatile than Compass Group PLC. It trades about 0.0 of its total potential returns per unit of risk. Compass Group PLC is currently generating about 0.09 per unit of volatility. If you would invest  181,554  in Compass Group PLC on November 2, 2024 and sell it today you would earn a total of  94,646  from holding Compass Group PLC or generate 52.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.18%
ValuesDaily Returns

Viridian Therapeutics  vs.  Compass Group PLC

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Viridian Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Compass Group PLC 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Compass Group PLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Compass Group may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Viridian Therapeutics and Compass Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Compass Group

The main advantage of trading using opposite Viridian Therapeutics and Compass Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Compass Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Group will offset losses from the drop in Compass Group's long position.
The idea behind Viridian Therapeutics and Compass Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges